Product information

From Health Canada

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Cancelled Post Market

Current status date:

2021-10-05

Original market date: See footnote 1

1964-12-31

Lot number: See footnote 2

1554-11

Product name:

SMALLPOX VACCINE (DRIED)

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.

DIN:

00075019

Product Monograph/Veterinary Labelling:

Date: 2020-09-30 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company:

SANOFI PASTEUR LIMITED
1755 Steeles Avenue West
Toronto
Ontario
Canada M2R 3T4

Class:

Human

Dosage form(s):

Powder For Solution

Route(s) of administration:

Intradermal

Number of active ingredient(s):

1

Schedule(s):

Schedule D

 

American Hospital Formulary Service (AHFS): See footnote 3

80:12.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

J07BX01 SMALLPOX AND MONKEYPOX VACCINES

Active ingredient group (AIG) number:See footnote5

0106228002

List of active ingredient(s)
Active ingredient(s) See footnote8 Strength
SMALLPOX VACCINE DRIED 100 M / ML
Version 4.0.3

"Page details"

Date modified: